Abstract
IntroductionDespite the availability of effective, subsidised hepatitis B treatment, linkage to care and treatment rates remain very low globally. In Australia, specially trained primary care physicians (general practitioner, GPs) can prescribe hepatitis B treatment, however, most hepatitis B care occurs in specialist clinics. Increasing hepatitis B management by GPs in primary care clinics is essential to achieve national hepatitis B linkage to care and treatment targets by 2030.This pilot study determines the feasibility, acceptability and effectiveness of Simply B, a novel GP hepatitis B e-support package designed to increase hepatitis B management by GPs in primary care clinics.Methods and analysisThis study will be conducted in three parts:Part A: A prospective open-label pilot intervention study, comparing the proportion of people with hepatitis B who are managed by their GP in primary care clinics before, 12 months and 24 months after implementation of the Simply B electronic hepatitis B support package.Part B: A nested qualitative health services feasibility study using semistructured interviews and thematic analysisPart C: Cost-effectiveness analysis.Ethics and disseminationThis study has received ethics approval by St Vincent’s Hospital. Data management and analysis will be centralised through the Department of Gastroenterology, St Vincent’s Hospital.Trial registration numberNCT05614466.
Reference20 articles.
1. MacLachlan J , Smith C , Towell V , et al . Viral hepatitis mapping project: national report 2018-2019. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM); 2020.
2. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific islands and territories: where are we now and barriers to meeting World Health organization targets by 2030;Howell;J Gastroenterol Hepatol,2019
3. Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission;Cooke;Lancet Gastroenterol Hepatol,2019
4. World Health Organization . Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030, licence: CC BY-NC-SA 3.0 IGO. Geneva,
5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance